Imported Disease Annotations - CTDObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | NEIL1 | Human | Dyslipidemias | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:16446448 | NEIL1 | Human | familial hyperlipidemia | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:21285402 | NEIL1 | Human | glucose intolerance | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:21285402 | NEIL1 | Human | hyperinsulinism | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:16446448 | NEIL1 | Human | Insulin Resistance | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:21285402 | NEIL1 | Human | Metabolic Syndrome | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:16446448 and PMID:17389588 | NEIL1 | Human | obesity | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:16446448 and PMID:21285402 | NEIL1 | Human | steatotic liver disease | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:16446448 and PMID:21285402 | |